Flosonics Medical Secures $7.5 Million CAD Venture Debt from RBCx to Scale Transformative Wearable Ultrasound Technology
Canadian medical device innovator, Flosonics Medical, has secured $7.5 million CAD in venture debt financing from RBCx.
Canadian medical device innovator, Flosonics Medical, has secured $7.5 million CAD in venture debt financing from RBCx.
The credit facility will fuel further AI product development, sales capacity, and M&A.
BIOTECanada, the national industry association representing the biotechnology ecosystem in Canada, is pleased to announce three new members joining the Board of Directors.
Backed by leading venture funds, the funding will propel Nmbr’s vision to simplify the process of building modern payroll products in Canada, helping companies launch payroll offerings to increase revenue [Read more]
Tony Barkett, Head, Banking. RBCx, discusses the current landscape following the collapse of SVB in Canada.
Devon Thompson, Managing Director, Banking, RBCx, discusses what's new in the second year of the RBCx Mentor Meetups program.
In this brief from The Logic, RBCx announced additions to its team to scale its Early Stage Banking and Life Sciences practices.
With the announcement that RBCx doubled down on its Life Sciences and Early Stage Banking practices, Betakit discusses the push to hire ex-SVB talent and where RBCx is headed in the market.